We are live on
!
Find out more
PIM
Profit Investment Management Portfolio holdings
AUM
$24.7M
1-Year Est. Return
21.29%
This Fund
S&P 500
This Quarter
Est. Return
+11.17%
1 Year Est. Return
+21.29%
3 Year Est. Return
+100.77%
5 Year Est. Return
+135.15%
10 Year Est. Return
+678.27%
AUM
$162M
AUM Growth
+$18.7M
(+13%)
Cap. Flow
+$6.66M
Cap. Flow
% of AUM
4.12%
Top 10 Holdings %
Top 10 Hldgs %
28.87%
Holding
91
New
8
Increased
43
Reduced
17
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Envista
NVST
|
+$2.58M |
| 2 |
Under Armour Class C
UA
|
+$1.1M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
+$947K |
| 4 |
Vanda Pharmaceuticals
VNDA
|
+$758K |
| 5 |
Gen Digital
GEN
|
+$281K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Evolent Health
EVH
|
+$1.47M |
| 2 |
Boston Beer
SAM
|
+$734K |
| 3 |
LOGM
LogMein, Inc.
LOGM
|
+$671K |
| 4 |
RTX Corp
RTX
|
+$540K |
| 5 |
Costco
COST
|
+$536K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 20.09% |
| 2 | Technology | 18.58% |
| 3 | Healthcare | 18.4% |
| 4 | Industrials | 13.25% |
| 5 | Financials | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
RTX Corp
RTX
$303B
| – | – |
-8,877
| Closed | -$540K |
|
77
Mastercard
MA
$510B
| $386K | 0.24% |
1,142
-80
| -7% | -$26K |
|
78
Bristol-Myers Squibb
BMY
$139B
| $370K | 0.23% |
6,137
| – | – |
|
79
Alphabet (Google) Class C
GOOG
$4.19T
| $370K | 0.23% |
5,040
+240
| +5% | +$18.3K |
|
80
Medtronic
MDT
$120B
| $299K | 0.18% |
2,889
+123
| +4% | +$12.4K |
|
|
81
Gen Digital
GEN
$16.8B
| $271K | 0.17% |
+12,996
| New | +$281K |
|
82
Yum! Brands
YUM
$40.2B
| $271K | 0.17% |
2,970
| – | – |
|
|
JHG
83
DELISTED
Janus Henderson
JHG
| $251K | 0.16% |
11,560
| – | – |
|
84
AT&T
T
$175B
| $223K | 0.14% |
10,368
-6,771
| -40% | -$151K |
|
|
GBL
85
DELISTED
GAMCO Investors, Inc.
GBL
| $219K | 0.14% |
+18,939
| New | +$238K |
|
86
Intel
INTC
$490B
| $217K | 0.13% |
4,199
-2,012
| -32% | -$105K |
|
87
Norfolk Southern
NSC
$78.7B
| $214K | 0.13% |
+1,000
| New | +$201K |
|
88
PayPal
PYPL
$52.8B
| $202K | 0.12% |
+1,023
| New | +$193K |
|
|
BMY.RT
89
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $23K | 0.01% |
+10,070
| New | +$28.8K |
|
|
90
Evolent Health
EVH
$520M
| – | – |
-206,234
| Closed | -$1.47M |
|
|
LOGM
91
DELISTED
LogMein, Inc.
LOGM
| – | – |
-7,919
| Closed | -$671K |
|
Similar funds
NCM
SWM
MVG
SM
MIG
VCG
CI
APM
Profit Investment Management's Q3 2020 Portfolio in Review
As of Q3 2020, Profit Investment Management held 91 positions worth $162M, up 13% from $143M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Profit Investment Management deployed $6.66M of net new capital in Q3 2020, opening 8 new positions and adding to 43 existing holdings. Its largest new stake was Envista: 112,134 shares worth $2.77M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Boston Beer, an estimated $734K trimmed.
- Profit Investment Management's largest Q3 2020 buy was Envista: 112,134 shares worth $2.77M.
- Profit Investment Management added most to Vanda Pharmaceuticals in Q3 2020, an estimated $758K increase.
- Profit Investment Management's biggest Q3 2020 reduction was Boston Beer, cutting an estimated $734K.
- Profit Investment Management fully exited Evolent Health in Q3 2020, selling an estimated $1.47M.
- Profit Investment Management's ten largest holdings make up 29% of its $162M portfolio in Q3 2020.
- Profit Investment Management opened 8 new positions and closed 3 in Q3 2020.
- Profit Investment Management's portfolio value rose 13% quarter-over-quarter to $162M.
Based on Profit Investment Management's 13F filing for Q3 2020, filed 9 Nov 2020.